Cambrian BioPharma Inc 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-04 4:41 pm Sale |
2023-07-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Cambrian BioPharma Inc | 3,653,120 14.600% |
-1,582,836 (-30.23%) |
Filing |
| 2023-02-14 11:36 am Purchase |
2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Cambrian BioPharma Inc | 5,235,956 17.000% |
4,468 (+0.09%) |
Filing |
| 2022-06-10 2:18 pm Purchase |
2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE |
Cambrian BioPharma Inc | 5,231,488 17.100% |
5,231,488 (New Position) |
Filing |